• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

RhoA determines disease progression by controlling neutrophil motility and restricting hyperresponsiveness

tetano

Editor, Senior Moderator
Blood. 2014 Apr 29. [Epub ahead of print]
RhoA determines disease progression by controlling neutrophil motility and restricting hyperresponsiveness.
Jennings RT1, Strengert M, Hayes P, El-Benna J, Brakebusch C, Kubica M, Knaus UG.
Author information
Abstract

Neutrophil responses are central to host protection and inflammation. Neutrophil activation follows a two-step process where priming amplifies responses to activating stimuli. Priming is essential for life span extension, chemotaxis and respiratory burst activity. Here we show that the cytoskeletal organizer RhoA suppresses neutrophil priming via formins. Premature granule exocytosis in Rho-deficient neutrophils activated numerous signaling pathways and amplified superoxide generation. Deletion of Rho altered front-to-back coordination by simultaneously increasing uropod elongation, leading edge formation and random migration. Concomitant negative and positive regulation of β2 integrin-independent and β2 integrin-dependent migration respectively, reveal Rho as a key decision point in the neutrophil response to discrete chemotactic agents. While even restricted influx of Rho-deficient hyperactive neutrophils exacerbated LPS-mediated lung injury, deleting Rho in innate immune cells was highly protective in Influenza A virus infection. Hence, Rho is a key regulator of disease progression by maintaining neutrophil quiescence and suppressing hyperresponsiveness.

PMID:
24782506
[PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/24782506
 
Back
Top Bottom